VERX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Vertex · Technology · Software - Application

Open interactive chart View report data
Latest close 12.91 USD
8.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -6.0% below the Trend Line and sits at 11.6% of its 52-week range. The latest completed week returned 8.8%, after a 0.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 68/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 0d.

Setup score 32 out of 100
Latest Close 12.91 USD 31 Jul 2026
1W Return 8.8% latest completed week
4W Return 0.5% short-term follow-through
12W Return -13.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 8.8% Latest completed week; four-week move 0.5%. Indicator stack 0/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 68/100 conviction; expected move 15.1%. News sentiment 52/100 67 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -6.0% below the Trend Line and sits at 11.6% of its 52-week range. The latest completed week returned 8.8%, after a 0.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2512-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.25Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.5% over four weeks, -13.5% over 12 weeks, and -60.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W8.8%
4W0.5%
12W-13.5%
26W-30.4%
52W-60.0%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.01Latest activity-pressure read.
Pressure change44.9%Four-week change in activity pressure.
Leadership-33.85Latest relative-leadership reading.
RS change21.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 80%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength19/100Blend of value, momentum, and quality. Underlying universe rank 82; rank 1 is best.
Value29/100Relative valuation strength. Underlying universe rank 72; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth72/100Revenue and earnings growth. Underlying universe rank 29; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.7x
Market value relative to trailing revenue.
EV / EBITDA
29.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
62.3%
Gross profit retained from each unit of revenue.
Operating margin
-0.9%
Operating profit retained from revenue.
Free-cash-flow margin
38.1%
Free cash flow generated from revenue.
Return on invested capital
-1.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
11.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
25.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

VERX shows volatility options pressure with a 68/100 conviction score, put-call volume ratio of 17.09, expected move of 15.1%, and Sharemaestro trend signal inactive.

Conviction68/100
Expected move15.1%
Put/call volume17.09
Pressure-83
Speculation46
Volatility88
Trend agreement55
Open options detail
Insider activity8 / 1

8 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 67 relevant articles.

16 positive · 45 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move15.1%Nearest-chain priced movement where available.
52-week drawdown-61.5%Distance below the 52-week high.
13-week volatility8.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+14.4%Week of 17 Apr.
Worst week-18.9%Week of 13 Feb.
Latest week+8.8%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains3
Flat weeks0
Modest losses5
Sharp losses9
Recent vol8.1%13-week weekly-return volatility.
Base vol7.9%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -6.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis34/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.25; No reversal markers Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 70; Small Cap Core rank 87 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options56/100

VERX shows volatility options pressure with a 68/100 conviction score, put-call volume ratio of 17.09, expected move of 15.1%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 15.1% Sentiment52/100

Weighted news tone is neutral across 67 relevant articles.

AbCellera Biologics (ABCL) Signs Vertex Deal, Is The Stock Still Cheap? Insiders8 / 1

8 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings0d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202612.91 USD8.8%13.74 USD29.28 USD1.01-33.8513.6MOff
24 Jul 202611.87 USD-7.3%13.94 USD29.32 USD0.95-40.4511.9MOff
17 Jul 202612.80 USD3.4%14.22 USD29.37 USD0.92-38.567.8MOff
10 Jul 202612.38 USD-3.7%14.46 USD29.41 USD0.78-44.636.7MOff
3 Jul 202612.85 USD13.0%14.71 USD29.45 USD0.70-43.109.0MOff
26 Jun 202611.37 USD2.2%14.94 USD29.48 USD0.72-50.599.9MOff
19 Jun 202611.12 USD-9.4%15.22 USD29.54 USD0.77-55.107.7MOff
12 Jun 202612.28 USD-6.7%15.51 USD29.59 USD0.88-50.516.1MOff
5 Jun 202613.16 USD-1.4%15.77 USD29.64 USD0.99-47.319.6MOff
29 May 202613.35 USD-0.7%15.98 USD29.70 USD1.01-50.546.5MOff
22 May 202613.44 USD4.6%16.30 USD29.76 USD0.88-50.296.2MOff
15 May 202612.85 USD-13.9%16.70 USD29.80 USD0.65-53.247.3MOff
8 May 202614.93 USD13.2%17.08 USD29.86 USD0.32-47.2911.3MOff
1 May 202613.19 USD5.4%17.41 USD29.89 USD-0.21-52.215.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.